Institute will seek permission to Anvisa for testing in humans.
Researchers at the Butantan Institute in Sao Paulo, are optimistic with a remedy made from the star tick saliva that may help in the treatment of cancer.To test the efficacy of the drug, they induced tumors of skin cancer in mice lung.After 14 days of drug therapy, the tumors almost disappeared.
"We had regression at first and had remission, that is, we end up with the tumor after thirty days of treatment," explains the study coordinator Ana Marisa Chudzinski-Tavassi.
For the researcher, the biggest advantage
of the drug is that it kills cancer cells without affecting healthy cells - which brings fewer side effects for patients.The drug was also effective against tumors in the pancreas and kidney - that are difficult to treat cancers.
The results obtained with the drug left the very excited researchers.Now they want to test the drug in people with cancer.There is no date for that to happen yet, but researchers expect it to be as soon as possible.Next week, the institute will seek permission to Anvisa for testing in humans.
Researchers at the Butantan Institute in Sao Paulo, are optimistic with a remedy made from the star tick saliva that may help in the treatment of cancer.To test the efficacy of the drug, they induced tumors of skin cancer in mice lung.After 14 days of drug therapy, the tumors almost disappeared.
"We had regression at first and had remission, that is, we end up with the tumor after thirty days of treatment," explains the study coordinator Ana Marisa Chudzinski-Tavassi.
For the researcher, the biggest advantage
of the drug is that it kills cancer cells without affecting healthy cells - which brings fewer side effects for patients.The drug was also effective against tumors in the pancreas and kidney - that are difficult to treat cancers.
The results obtained with the drug left the very excited researchers.Now they want to test the drug in people with cancer.There is no date for that to happen yet, but researchers expect it to be as soon as possible.Next week, the institute will seek permission to Anvisa for testing in humans.